Key Takeaways Same ingredient, different approvals – Both Zepbound and Mounjaro contain tirzepatide, but Zepbound is FDA-approved for chronic weight management, while Mounjaro is approved for type 2 diabetes. Weight loss outcomes – Clinical trials show Zepbound users achieve greater average weight loss (up to ~22%) compared with Mounjaro users (~15%), reflecting its weight-focused dosing protocols. Coverage drives access – Insurance typically favors Mounjaro for diabetes,

August 18, 2025, Novo Nordisk has reduced the out-of-pocket cost of Ozempic® (semaglutide) to $499 per month for U.S. patients with type...

For more information on our content creation process, view our Editorial Policy . Key Takeaways 1,200 calories creates a deficit , often...

For more information on our content creation process, view our Editorial Policy . Key Takeaways: Dual benefits:  Ozempic helps manage type 2 diabetes while also supporting weight loss, even though it’s not officially marketed as a weight-loss drug. Alternatives exist:  Other GLP-1 medications, such as Mounjaro, Trulicity, Rybelsus, and Wegovy, as well as non-GLP-1 options like Metformin, offer comparable or complementary results. Personalized choice matters:  The “best” optio

For more information on our content creation process, view our Editorial Policy . Key takeaways Chronic inflammation fuels disease  —...

For more information on our content creation process, view our Editorial Policy . Key Takeaways: Clopidogrel’s effectiveness can be...

For more information on our content creation process, view our Editorial Policy . Key Takeaways: Hunger doesn’t always mean appetite ,...

For more information on our content creation process, view our Editorial Policy . Key Takeaways: Whole-Food Ingredients, No Junk  –...

For more information on our content creation process, view our Editorial Policy . Key Takeaways: This 7-day meal plan is designed to...